GobyMeds: A Personalized Path to Compounded GLP-1 Support GobyMeds offers a simple way to connect with licensed providers who can determine if compounded GLP-1 or GLP-1/GIP therapy may be right for you
While the patenting behavior around tirzepatide is still early in its life cycle as compared to semaglutide, it already demonstrates how Eli Lilly has built a thicket of patents that extends its patent protection
For now, we're sticking with our safe and proven treatment programmes: Wegovy, Mounjaro and meal replacement diet plans
Your growing baby needs you to eat enough nutrients
According to the International Foundation of Employee Benefit Plans, as of 2025: 55% of employers cover GLP-1 medications only for diabetes through their health plans, down from 57%in 2024 36% cover GLP-1 medications for both diabetes and weight loss through their health plans, up from 34%in 2024 Other sources report a much higher GLP-1 coverage for weight loss, between 49% and 57% among employers
As a result, detox processes can run more smoothly